ImpeDx Diagnostics

company

About

ImpeDx Diagnostics, a start-up medical device company.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$225K
Industries
Biotechnology,Health Diagnostics,Medical,Medical Device
Founded date
Jan 1, 2013
Number Of Employee
1 - 10
Operating Status
Active

ImpeDx Diagnostics is a start-up medical device company founded in 2013, that has secured exclusive rights to develop and market a novel system for rapid detecting bacteria in blood culture specimens for use in clinical laboratories.

Their mission is to reduce the mortality rate of septic patients by providing rapid diagnostic products, which will allow clinicians to administer target therapeutic treatments sooner. Their technology compresses blood culture results from days to hours. Not only will rapid identification improve the mortality rate, but it will also have a major impact on healthcare savings.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$0.95M
ImpeDx Diagnostics has raised a total of $0.95M in funding over 2 rounds. Their latest funding was raised on Sep 8, 2018 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 8, 2018 Grant $730.18K 1 National Science Foundation Detail
Dec 1, 2016 Grant $225K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
2
1
ImpeDx Diagnostics is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant